News Detail
New Delhi, 17 Feb 2025: Drug firms Glenmark Pharmaceuticals and FDC Ltd are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA).
In its latest Enforcement Report, the US health regulator ......
View Details
Source : PTI
Healthcare in India
Glenmark Pharmaceuticals
Pharmaceutical industry in India
Food and Drug Administration
Glenmark
Pharmaceutical industry in China
Pharmaceutical industry of Gujarat
Aurobindo Pharma
Zydus Lifesciences
Government Administration Activities
Pharmaceuticals (NEC)
glaucoma
GLENMARK PHARMACEUTICALS INC
Carvedilol
New Jersey
Carvediol
mg
Timolol Maleate
FDC Ltd
certain number of a generic hypertension medication
Mumbai
medication
United States
US FOOD AND DRUG ADMINISTRATION
Aurangabad
US Food and Drug Administration
generic hypertension
treatment of glaucoma
violative product
Container
Related News
- Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel (25-03-2025)
- Supplement firm Bioventra warns of online fakes (25-03-2025)
- FDA drug approvals drops, but smaller pharma leads innovation: GlobalData (25-03-2025)
- No staff involved in promoting fake drugs, vaccination: Odisha Health Minister (25-03-2025)
- Centre to introduce standardised hospital billing format to ensure transparency (24-03-2025)
- CDSCO asks MSME pharma firms to apply online for Schedule M extension (24-03-2025)
- Father and son arrested for unlicensed medicine sales, concealed drugs in cowshed (24-03-2025)
- AI-driven device by PGI set to transform neuropathic pain diagnosis (24-03-2025)
- Chhattisgarh EOW Arrests Five Officers in ₹660 Cr Procurement Scam (24-03-2025)
- Man caught at Silchar Medical College for allegedly overpricing medicines (24-03-2025)